相关实验视频
Updated: Jul 12, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.8K
人工智能,计算模拟和扩展现实在心血管干预中的应用.
Saurabhi Samant1, Jules Joel Bakhos1, Wei Wu1
1Center for Digital Cardiovascular Innovations, Division of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA; Cardiovascular Biology and Biomechanics Laboratory (CBBL), Cardiovascular Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
JACC. Cardiovascular interventions
|October 25, 2023
概括
人工智能,计算模拟和扩展现实 (AISER) 正在改变心血管疗法. 本综述探讨了AISER在规划,试验,设备开发和培训中的应用,以及挑战和解决方案.
科学领域:
- 心血管医学 心血管医学
- 计算技术 计算技术 计算技术
- 医学创新 医学创新
背景情况:
- 21世纪的计算技术正在彻底改变医疗保健.
- 人工智能,计算模拟和扩展现实为医学提供了巨大的潜力.
研究的目的:
- 审查人工智能,计算模拟和扩展现实 (AISER) 在心血管治疗中的进步和好处.
- 突出AISER在心血管干预中的关键应用,挑战和解决方案.
主要方法:
- 关于AISER在心血管医学中的应用的综合文献综述.
- 分析临床实践和研究中的当前和新兴用途.
主要成果:
- AISER的应用涵盖了程序前规划,临床决策和虚拟临床试验.
- 这些技术对于心血管设备的研究,开发和监管批准至关重要.
- AISER显著提高了医疗保健专业人员和创新者的教育和培训.
结论:
- AISER技术在心血管干预和医学中呈现出一种范式的转变.
- 解决已识别的障碍对于广泛采用和最大化收益至关重要.
- 为了简化AISER实施,不同利益相关者之间的合作至关重要.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15

